FDA Inspection
Hospira, Inc.Hospira, Inc. – FDA Inspection, Aug 4, 2011
Record Details
This FDA Inspection record concerns Hospira, Inc., with an inspection on August 4, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hospira, Inc.
- Inspection Date
- August 4, 2011
- Product Type
- Drugs
View Company Profile
ID · 7f3c024e-9b6e-47f6-b327-09bb2ebc0603
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 740633
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hospira, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | Not classified | Atlanta District Office | |
| November 14, 2023 | OAI | Atlanta District Office | |
| November 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hospira, Inc.
- FDA Inspection 1251941 - 2025-02-07
- FDA Inspection 1223090 - 2023-11-14
- FDA Inspection 1110899 - 2019-11-21
- FDA Inspection 1039547 - 2018-02-02
- FDA Inspection 984874 - 2016-05-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.